Global Platinum based Cancer Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 21-Aug-2018
No. of pages: 122

Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.

Scope of the Report:

This report focuses on the Platinum based Cancer Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Asia-Pacific is the largest sales place, with a sales market share nearly 42% in 2017. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 20%.

The worldwide market for Platinum based Cancer Drug is expected to grow at a CAGR of roughly 3.5% over the next five years, will reach 1580 million US$ in 2023, from 1290 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Sanofi

- Hengrui Medicine

- ASK Pharma

- Yi Bai Pharmaceutical

- Qilu Pharmaceutical

- Teva

- Pfizer

- Dr Reddy's Laboratories

- Mylan

- Sun Pharma

- Novartis

- Debiopharm

- Accord Healthcare

- SK Chemicals

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Cisplatin

- Oxaliplatin

- Carboplatin

- Other

Market Segment by Applications, can be divided into

- Colorectal Cancer

- Ovarian Cancer

- Lung Cancer

- Other

There are 15 Chapters to deeply display the global Platinum based Cancer Drug market.

Chapter 1, to describe Platinum based Cancer Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Platinum based Cancer Drug, with sales, revenue, and price of Platinum based Cancer Drug, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Platinum based Cancer Drug, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Platinum based Cancer Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Platinum based Cancer Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Platinum based Cancer Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Platinum based Cancer Drug Introduction
1.2 Market Analysis by Type
1.2.1 Cisplatin
1.2.2 Oxaliplatin
1.2.3 Carboplatin
1.2.4 Other
1.3 Market Analysis by Applications
1.3.1 Colorectal Cancer
1.3.2 Ovarian Cancer
1.3.3 Lung Cancer
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Business Overview
2.1.2 Platinum based Cancer Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sanofi Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Hengrui Medicine
2.2.1 Business Overview
2.2.2 Platinum based Cancer Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Hengrui Medicine Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 ASK Pharma
2.3.1 Business Overview
2.3.2 Platinum based Cancer Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 ASK Pharma Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Yi Bai Pharmaceutical
2.4.1 Business Overview
2.4.2 Platinum based Cancer Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Yi Bai Pharmaceutical Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Qilu Pharmaceutical
2.5.1 Business Overview
2.5.2 Platinum based Cancer Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Qilu Pharmaceutical Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Teva
2.6.1 Business Overview
2.6.2 Platinum based Cancer Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Teva Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Platinum based Cancer Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Dr Reddy's Laboratories
2.8.1 Business Overview
2.8.2 Platinum based Cancer Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Dr Reddy's Laboratories Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Mylan
2.9.1 Business Overview
2.9.2 Platinum based Cancer Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Mylan Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sun Pharma
2.10.1 Business Overview
2.10.2 Platinum based Cancer Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sun Pharma Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Novartis
2.11.1 Business Overview
2.11.2 Platinum based Cancer Drug Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Novartis Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Debiopharm
2.12.1 Business Overview
2.12.2 Platinum based Cancer Drug Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Debiopharm Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Accord Healthcare
2.13.1 Business Overview
2.13.2 Platinum based Cancer Drug Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Accord Healthcare Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 SK Chemicals
2.14.1 Business Overview
2.14.2 Platinum based Cancer Drug Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 SK Chemicals Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Platinum based Cancer Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Platinum based Cancer Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Platinum based Cancer Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Platinum based Cancer Drug Manufacturer Market Share in 2017
3.3.2 Top 6 Platinum based Cancer Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Platinum based Cancer Drug Market Analysis by Regions
4.1 Global Platinum based Cancer Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Platinum based Cancer Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Platinum based Cancer Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
4.3 Europe Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
4.5 South America Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
5 North America Platinum based Cancer Drug by Countries
5.1 North America Platinum based Cancer Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Platinum based Cancer Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Platinum based Cancer Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
5.3 Canada Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
6 Europe Platinum based Cancer Drug by Countries
6.1 Europe Platinum based Cancer Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Platinum based Cancer Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Platinum based Cancer Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
6.3 UK Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
6.4 France Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
6.5 Russia Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
6.6 Italy Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Platinum based Cancer Drug by Countries
7.1 Asia-Pacific Platinum based Cancer Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Platinum based Cancer Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Platinum based Cancer Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
7.3 Japan Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
7.4 Korea Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
7.5 India Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
8 South America Platinum based Cancer Drug by Countries
8.1 South America Platinum based Cancer Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Platinum based Cancer Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Platinum based Cancer Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Platinum based Cancer Drug by Countries
9.1 Middle East and Africa Platinum based Cancer Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Platinum based Cancer Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Platinum based Cancer Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
9.3 UAE Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
10 Global Platinum based Cancer Drug Market Segment by Type
10.1 Global Platinum based Cancer Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Platinum based Cancer Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Platinum based Cancer Drug Revenue and Market Share by Type (2013-2018)
10.2 Cisplatin Sales Growth and Price
10.2.1 Global Cisplatin Sales Growth (2013-2018)
10.2.2 Global Cisplatin Price (2013-2018)
10.3 Oxaliplatin Sales Growth and Price
10.3.1 Global Oxaliplatin Sales Growth (2013-2018)
10.3.2 Global Oxaliplatin Price (2013-2018)
10.4 Carboplatin Sales Growth and Price
10.4.1 Global Carboplatin Sales Growth (2013-2018)
10.4.2 Global Carboplatin Price (2013-2018)
10.5 Other Sales Growth and Price
10.5.1 Global Other Sales Growth (2013-2018)
10.5.2 Global Other Price (2013-2018)
11 Global Platinum based Cancer Drug Market Segment by Application
11.1 Global Platinum based Cancer Drug Sales Market Share by Application (2013-2018)
11.2 Colorectal Cancer Sales Growth (2013-2018)
11.3 Ovarian Cancer Sales Growth (2013-2018)
11.4 Lung Cancer Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 Platinum based Cancer Drug Market Forecast (2018-2023)
12.1 Global Platinum based Cancer Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Platinum based Cancer Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Platinum based Cancer Drug Market Forecast (2018-2023)
12.2.2 Europe Platinum based Cancer Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Platinum based Cancer Drug Market Forecast (2018-2023)
12.2.4 South America Platinum based Cancer Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Platinum based Cancer Drug Market Forecast (2018-2023)
12.3 Platinum based Cancer Drug Market Forecast by Type (2018-2023)
12.3.1 Global Platinum based Cancer Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Platinum based Cancer Drug Market Share Forecast by Type (2018-2023)
12.4 Platinum based Cancer Drug Market Forecast by Application (2018-2023)
12.4.1 Global Platinum based Cancer Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Platinum based Cancer Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Platinum based Cancer Drug Picture
Table Product Specifications of Platinum based Cancer Drug
Figure Global Sales Market Share of Platinum based Cancer Drug by Types in 2017
Table Platinum based Cancer Drug Types for Major Manufacturers
Figure Cisplatin Picture
Figure Oxaliplatin Picture
Figure Carboplatin Picture
Figure Other Picture
Figure Platinum based Cancer Drug Sales Market Share by Applications in 2017
Figure Colorectal Cancer Picture
Figure Ovarian Cancer Picture
Figure Lung Cancer Picture
Figure Other Picture
Figure United States Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure France Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure UK Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure China Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure India Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Platinum based Cancer Drug Type and Applications
Table Sanofi Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table Hengrui Medicine Platinum based Cancer Drug Type and Applications
Table Hengrui Medicine Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table ASK Pharma Basic Information, Manufacturing Base and Competitors
Table ASK Pharma Platinum based Cancer Drug Type and Applications
Table ASK Pharma Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Yi Bai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Yi Bai Pharmaceutical Platinum based Cancer Drug Type and Applications
Table Yi Bai Pharmaceutical Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Qilu Pharmaceutical Platinum based Cancer Drug Type and Applications
Table Qilu Pharmaceutical Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Platinum based Cancer Drug Type and Applications
Table Teva Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Platinum based Cancer Drug Type and Applications
Table Pfizer Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Dr Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table Dr Reddy's Laboratories Platinum based Cancer Drug Type and Applications
Table Dr Reddy's Laboratories Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Platinum based Cancer Drug Type and Applications
Table Mylan Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sun Pharma Basic Information, Manufacturing Base and Competitors
Table Sun Pharma Platinum based Cancer Drug Type and Applications
Table Sun Pharma Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Platinum based Cancer Drug Type and Applications
Table Novartis Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Debiopharm Basic Information, Manufacturing Base and Competitors
Table Debiopharm Platinum based Cancer Drug Type and Applications
Table Debiopharm Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table Accord Healthcare Platinum based Cancer Drug Type and Applications
Table Accord Healthcare Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table SK Chemicals Basic Information, Manufacturing Base and Competitors
Table SK Chemicals Platinum based Cancer Drug Type and Applications
Table SK Chemicals Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Platinum based Cancer Drug Sales by Manufacturer (2016-2017)
Figure Global Platinum based Cancer Drug Sales Market Share by Manufacturer in 2016
Figure Global Platinum based Cancer Drug Sales Market Share by Manufacturer in 2017
Table Global Platinum based Cancer Drug Revenue by Manufacturer (2016-2017)
Figure Global Platinum based Cancer Drug Revenue Market Share by Manufacturer in 2016
Figure Global Platinum based Cancer Drug Revenue Market Share by Manufacturer in 2017
Figure Top 3 Platinum based Cancer Drug Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Platinum based Cancer Drug Manufacturer (Revenue) Market Share in 2017
Figure Global Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Global Platinum based Cancer Drug Revenue and Growth Rate (2013-2018)
Table Global Platinum based Cancer Drug Sales by Regions (2013-2018)
Table Global Platinum based Cancer Drug Sales Market Share by Regions (2013-2018)
Table Global Platinum based Cancer Drug Revenue by Regions (2013-2018)
Figure Global Platinum based Cancer Drug Revenue Market Share by Regions in 2013
Figure Global Platinum based Cancer Drug Revenue Market Share by Regions in 2017
Figure North America Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Europe Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure South America Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure North America Platinum based Cancer Drug Revenue and Growth Rate (2013-2018)
Table North America Platinum based Cancer Drug Sales by Countries (2013-2018)
Table North America Platinum based Cancer Drug Sales Market Share by Countries (2013-2018)
Figure North America Platinum based Cancer Drug Sales Market Share by Countries in 2013
Figure North America Platinum based Cancer Drug Sales Market Share by Countries in 2017
Table North America Platinum based Cancer Drug Revenue by Countries (2013-2018)
Table North America Platinum based Cancer Drug Revenue Market Share by Countries (2013-2018)
Figure North America Platinum based Cancer Drug Revenue Market Share by Countries in 2013
Figure North America Platinum based Cancer Drug Revenue Market Share by Countries in 2017
Figure United States Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Canada Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Mexico Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Europe Platinum based Cancer Drug Revenue and Growth Rate (2013-2018)
Table Europe Platinum based Cancer Drug Sales by Countries (2013-2018)
Table Europe Platinum based Cancer Drug Sales Market Share by Countries (2013-2018)
Table Europe Platinum based Cancer Drug Revenue by Countries (2013-2018)
Figure Europe Platinum based Cancer Drug Revenue Market Share by Countries in 2016
Figure Europe Platinum based Cancer Drug Revenue Market Share by Countries in 2017
Figure Germany Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure UK Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure France Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Russia Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Italy Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Platinum based Cancer Drug Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Platinum based Cancer Drug Sales by Countries (2013-2018)
Table Asia-Pacific Platinum based Cancer Drug Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Platinum based Cancer Drug Sales Market Share by Countries 2017
Table Asia-Pacific Platinum based Cancer Drug Revenue by Countries (2013-2018)
Figure Asia-Pacific Platinum based Cancer Drug Revenue Market Share by Countries 2017
Figure China Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Japan Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Korea Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure India Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Southeast Asia Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure South America Platinum based Cancer Drug Revenue and Growth Rate (2013-2018)
Table South America Platinum based Cancer Drug Sales by Countries (2013-2018)
Table South America Platinum based Cancer Drug Sales Market Share by Countries (2013-2018)
Figure South America Platinum based Cancer Drug Sales Market Share by Countries in 2017
Table South America Platinum based Cancer Drug Revenue by Countries (2013-2018)
Table South America Platinum based Cancer Drug Revenue Market Share by Countries (2013-2018)
Figure South America Platinum based Cancer Drug Revenue Market Share by Countries in 2017
Figure Brazil Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Argentina Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Colombia Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Platinum based Cancer Drug Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Platinum based Cancer Drug Sales by Countries (2013-2018)
Table Middle East and Africa Platinum based Cancer Drug Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Platinum based Cancer Drug Sales Market Share by Countries in 2017
Table Middle East and Africa Platinum based Cancer Drug Revenue by Countries (2013-2018)
Table Middle East and Africa Platinum based Cancer Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Platinum based Cancer Drug Revenue Market Share by Countries in 2013
Figure Middle East and Africa Platinum based Cancer Drug Revenue Market Share by Countries in 2017
Figure Saudi Arabia Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure UAE Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Egypt Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Nigeria Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure South Africa Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Table Global Platinum based Cancer Drug Sales by Type (2013-2018)
Table Global Platinum based Cancer Drug Sales Share by Type (2013-2018)
Table Global Platinum based Cancer Drug Revenue by Type (2013-2018)
Table Global Platinum based Cancer Drug Revenue Share by Type (2013-2018)
Figure Global Cisplatin Sales Growth (2013-2018)
Figure Global Cisplatin Price (2013-2018)
Figure Global Oxaliplatin Sales Growth (2013-2018)
Figure Global Oxaliplatin Price (2013-2018)
Figure Global Carboplatin Sales Growth (2013-2018)
Figure Global Carboplatin Price (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Other Price (2013-2018)
Table Global Platinum based Cancer Drug Sales by Application (2013-2018)
Table Global Platinum based Cancer Drug Sales Share by Application (2013-2018)
Figure Global Ovarian Cancer Sales Growth (2013-2018)
Figure Global Lung Cancer Sales Growth (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Platinum based Cancer Drug Sales, Revenue and Growth Rate (2018-2023)
Table Global Platinum based Cancer Drug Sales Forecast by Regions (2018-2023)
Table Global Platinum based Cancer Drug Market Share Forecast by Regions (2018-2023)
Figure North America Sales Platinum based Cancer Drug Market Forecast (2018-2023)
Figure Europe Sales Platinum based Cancer Drug Market Forecast (2018-2023)
Figure Asia-Pacific Sales Platinum based Cancer Drug Market Forecast (2018-2023)
Figure South America Sales Platinum based Cancer Drug Market Forecast (2018-2023)
Figure Middle East and Africa Sales Platinum based Cancer Drug Market Forecast (2018-2023)
Table Global Platinum based Cancer Drug Sales Forecast by Type (2018-2023)
Table Global Platinum based Cancer Drug Market Share Forecast by Type (2018-2023)
Table Global Platinum based Cancer Drug Sales Forecast by Application (2018-2023)
Table Global Platinum based Cancer Drug Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Levonorgestrel Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 130
    Levonorgestrel is a hormonal medication which is used in a number of birth control methods. In pill form, sold under the brand name Plan B among others, it is useful within 120 hours as emergency birth control. It becomes less effective the longer after sex and only works before pregnancy has occurred. It is also combined with an estrogen to make Mixture Products. Within an intrauterine device (IUD), sold as Mirena among others, it is effective for long-term prevention of pregnancy. An implantab......
  • Global Equine Pharmaceuticals and Supplements Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 158
    Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases. In the last several years, global market of Equine Pharmaceuticals and Supplements developed rapidly, with an average growth rate of 4.52% during 2013 to 2017. In 2017, global revenue of Equine Pharmaceuticals and Supplements is nearly 977 M USD; the actual production is about 13700 K Unit. Market competition is not intense. Boehringer Ingelheim, Me......
  • Global Cabazitaxel Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 132
    Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy. Global cabazitaxel production regions are mainly distributed in USA and Europe. There is no doubt that USA is the largest production region in the world. In......
  • Global Rydapt Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 139
    Rydapt is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and advanced systemic mastocytosis. North America is the largest Sales place, with a Sales market share nearly 75.2% in 2017. Following North America, Europe is the second largest Sales place with the Sales market share of 24.8%. In USA, The National Cancer Institute estimates that in 2017 approximately 21,380 people will be diagn......
  • Global Hyperimmune Globulins Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 159
    Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccine......
  • Global Transforming Growth Factor Beta 1 Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 139
    Transforming growth factor beta 1 or TGF-ß1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-ß1 is encoded by the TGFB1 gene North America is the largest consumption place, with a consumption market share nearly 61.5% in 2017. Following North America, Asia-Pacific and Europe is ......
  • Global Traveler's Diarrhea Therapeutics Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 139
    Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week. Traveler's diarrhea is the leading cause of illness among international tra......
  • Global Anticoagulant Drugs Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 130
    Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time. According to this study, over the next five years the Anticoagulant Drugs market will register a 5.0% CAGR in terms of revenue, the global market size will reach US$ 31300 million by 2024, from US$ 24600 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Anticoag......
  • Global OTC Herbal and Traditional Medicines Market Growth 2019-2024
    Published: 23-Jan-2019        Price: US 3660 Onwards        Pages: 184
    Herbal medicine--also called botanical medicine or phytomedicine refers to using a plant's seeds, berries, roots, leaves, bark, or flowers for medicinal purposes. Herbalism has a long tradition of use outside of conventional medicine. It is becoming more mainstream as improvements in analysis and quality control along with advances in clinical research show the value of herbal medicine in the treating and preventing disease. Herbal medicine industry is dispersive relatively. Currently, th......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs